Oscar Otero-Marquez
Overview
Explore the profile of Oscar Otero-Marquez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wei W, Mazzola M, Otero-Marquez O, Tong Y, Souied E, Querques G, et al.
Eye (Lond)
. 2023 Jan;
37(11):2281-2288.
PMID: 36617586
Background/aims: To demonstrate two distinct pathways to geographic atrophy (GA) that originate from soft drusen/ pigment epithelial detachments (PEDs) and subretinal drusenoid deposits (SDDs), respectively, and are characterized by their...
12.
Pinhas A, Migacz J, Zhou D, Castanos Toral M, Otero-Marquez O, Israel S, et al.
Ophthalmol Sci
. 2022 Dec;
2(4):100196.
PMID: 36531581
Purpose: Clinical OCT angiography (OCTA) of the retinal microvasculature offers a quantitative correlate to systemic disease burden and treatment efficacy in sickle cell disease (SCD). The purpose of this study...
13.
Otero-Marquez O, Ahsanuddin S, Spellman L, Pinhas A, Chui T, Rosen R
Eur J Ophthalmol
. 2022 Nov;
33(6):NP118-NP121.
PMID: 36377274
Introduction: Vitreous cortex hyalocytes (VCH) are resident macrophage cells that provide immunosurveillance, respond to tissue injury and inflammation, and help maintain the transparency of the media. In this case report...
14.
Schatz M, Otero-Marquez O, Rosen R, Parikh D
Case Rep Ophthalmol Med
. 2022 Nov;
2022:2855191.
PMID: 36329692
Though rare, acute macular neuroretinopathy is a well-described clinical entity. We report for the first time a detailed analysis of macular hyalocyte count and morphology during the acute phase of...
15.
Ledesma-Gil G, Querques G, Souied E, Smith R, Otero-Marquez O, Mainster M
Retina
. 2022 Sep;
42(10):e48-e49.
PMID: 36129271
No abstract available.
16.
Pinhas A, Zhou D, Otero-Marquez O, Castanos Toral M, Migacz J, Glassberg J, et al.
Case Rep Hematol
. 2022 Sep;
2022:6079631.
PMID: 36046774
Sickle cell disease (SCD) exists on a phenotypic spectrum with variable genetic expressivity, making it difficult to assess an individual patient's risk of complications at any particular point in time....
17.
Migacz J, Otero-Marquez O, Zhou R, Rickford K, Murillo B, Zhou D, et al.
Biomed Opt Express
. 2022 Apr;
13(3):1755-1773.
PMID: 35414987
Vitreous cortex hyalocytes are resident macrophage cells that help maintain the transparency of the media, provide immunosurveillance, and respond to tissue injury and inflammation. In this study, we demonstrate the...
18.
Pinhas A, Andrade Romo J, Lynch G, Zhou D, Castanos Toral M, Tenzel P, et al.
Clin Ophthalmol
. 2022 Mar;
16:867-875.
PMID: 35340669
Purpose: Hemodynamic changes surrounding the optic nerve head are known to occur in thyroid-related orbitopathy (TRO). This pilot study explores the capillary and non-capillary peripapillary perfusion changes of the retina...
19.
Thomson R, Chazaro J, Otero-Marquez O, Ledesma-Gil G, Tong Y, Coughlin A, et al.
Retina
. 2022 Feb;
42(7):1311-1318.
PMID: 35213528
Purpose: Soft drusen and subretinal drusenoid deposits (SDDs) characterize two pathways to advanced age-related macular degeneration (AMD), with distinct genetic risks, serum risks, and associated systemic diseases. Methods: One hundred...
20.
Otero-Marquez O, Chui T, Pinhas A, Castanos Toral M, Zhou D, Migacz J, et al.
Am J Ophthalmol Case Rep
. 2022 Feb;
25:101394.
PMID: 35198818
Purpose: To report the impact of intravitreal anti-vascular endothelial growth factor (VEGF) therapy on a retinal capillary hemangioma (RCH) using clinical OCT angiography (OCT-A) in addition to standard imaging modalities....